-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RLS-0071 in Hypoxic-Ischemic Encephalopathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RLS-0071 in Hypoxic-Ischemic Encephalopathy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RLS-0071 in Hypoxic-Ischemic Encephalopathy Drug Details: RLS-0071 (PIC1-01) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RLS-0071 in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RLS-0071 in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RLS-0071 in Chronic Obstructive Pulmonary Disease (COPD) Drug...
-
Product Insights
NewNet Present Value Model: Atai Life Sciences NV’s RL-007
Empower your strategies with our Net Present Value Model: Atai Life Sciences NV's RL-007 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Naltrexone in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Naltrexone in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Naltrexone in Treatment Resistant Depression Drug Details: Naltrexone is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RL-007 in Diabetic Neuropathic Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RL-007 in Diabetic Neuropathic Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RL-007 in Diabetic Neuropathic Pain Drug Details:RL-007 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RL-007 in Cognitive Impairment Associated With Schizophrenia (CIAS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RL-007 in Cognitive Impairment Associated With Schizophrenia (CIAS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RL-007 in Cognitive Impairment Associated With Schizophrenia (CIAS)Drug Details:RL-007...
-
Sector Analysis
North America Oil and Gas Projects by Development Stage, Capacity, Capex, Contractor Details of All New Build and Expansion Projects to 2028
North America Oil and Gas Projects Analytics Report Overview GlobalData expects over 550 oil & gas projects to commence operations in North America during 2024-2028. Out of these, upstream projects would be 74, midstream would be the highest with 263 projects, with refinery and petrochemicals at 102 and 119, respectively. The North America Oil and Gas Projects Analytics Report offers a detailed analysis of planned and announced projects in the region across the oil and gas value chain. The report...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tuparstobart in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tuparstobart in Non-Small Cell Lung Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tuparstobart in Non-Small Cell Lung Cancer Drug Details: Tuparstobart (INCAGN-2385)...
-
Product Insights
NewNet Present Value Model: Rezolute Inc’s RZ-358
Empower your strategies with our Net Present Value Model: Rezolute Inc's RZ-358 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Mazindol ER in Idiopathic Hypersomnia (IH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mazindol ER in Idiopathic Hypersomnia (IH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mazindol ER in Idiopathic Hypersomnia (IH) Drug Details: Mazindol ER...